PatientsVisitorsLocations & ServicesAbout the RegionJoin Our TeamPhysicians
Find:  Locations | Services
Pathology and Laboratory Medicine HomeTest and Services CatalogueTransfusion Medicine Product CataloguePolicy and ProcedureJob AidsSpecimen Collection and TransportRequisitionsAntibiogramsGenetic Testing and Molecular GeneticsMicrobiology EssentialsTransfusion EssentialsReference RangesLaboratory SuppliesAcute Care SCM GuidelinesContact InformationPhysician Access to Patient ResultsNew Clinic or Provider Information Changes
Pathology and Laboratory Medicine
Product Catalogue

​Hepatitis B Immune Globulin

Transfusion Medicine

​Alternate Product Names
  • ​HBIG
  • Hyperhep
  • Hepagam
​Indications
  • ​Hepatitis B post-exposure prophylaxis
​Resource Information

Product Information:

Product Monograph (Hepatitis B Immune Globulin (HyperHEP B® S/D)):

HepaGam B®:

Size/Volume Available
  • HyperHEP B® S/D: 0.5 mL and 5 mL
  • HepaGam B®: 3 mL or 6 mL (>312 IU/mL)
Availability
​Size​RUH​SCH​SPH​Rural
​0.5 mL
​Yes​No​NoContact Public Health​ ​
​5.0 mL
​Yes​Yes​Yes
Pretransfusion Testing Requirements
  • ​None required
Forms Required

​Saskatoon:

Rural:

  • Contact Public Health
Ordering
  • Indicate dosage required (total mL volume)
  • Patient weight (kg), address, home phone number and reason for use must be indicated
    • If recipient is a neonate, indicate mother’s first and last name
  • Saskatoon lab only:
    • TIG/HBIG/Hepatitis B/ RIG/Rabies Vaccine Recipients Form (DC-101) shall be completed and faxed to Disease Control Public Health Services (PHS) when product is issued
    • Indication of PHS notification shall be made in Transfusion Medicine LIS
​Notes
  • ​Saskatoon: Public Health will be notified when product has been issued
  • Should be administered preceding or concomitantly with Hepatitis B vaccination as a part of Hepatitis B post-exposure prophylaxis
  • A Transfusion Medicine/Canadian Blood Services chart report is NOT required for product infusion
​Administration
  • ​See product monograph.  For intramuscular injection only.
  • Contains human protein; informed patient consent required for this product

 

​If you choose to print this information, it is valid only on date of print.

Laboratory Controlled Document LSM-60 v4

Last Modified: Thursday, September 29, 2016 |
Questions or feedback about this page?